Literature DB >> 3857589

Transformation of human cells by DNAs ineffective in transformation of NIH 3T3 cells.

B M Sutherland, P V Bennett, A G Freeman, S P Moore, P T Strickland.   

Abstract

Neonatal human foreskin fibroblasts can be transformed to anchorage-independent growth by transfection with DNAs inefficient in transforming NIH 3T3 cells. Human cells transfected with DNA from GM 1312, a multiple myeloma cell line, or MOLT-4, a permanent lymphoblast line, grow without anchorage at a much higher frequency than do the parental cells and their DNAs can transform human cell recipients to anchorage-independent growth; they have extended but not indefinite life spans and are nontumorigenic. Human fibroblasts are also transformed by DNAs from two multiple myeloma lines that also transform 3T3 cells; however, restriction analysis suggests that different transforming genes in this DNA are acting in the human and murine systems. These results indicate that the human cell transfection system allows detection of transforming genes not effective in the 3T3 system and points out the possibility of detection of additional transforming sequences even in DNAs that do transform murine cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3857589      PMCID: PMC397565          DOI: 10.1073/pnas.82.8.2399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Neoplastic transformation of human diploid fibroblast cells by chemical carcinogens.

Authors:  T Kakunaga
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

2.  T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes.

Authors:  E Santos; S R Tronick; S A Aaronson; S Pulciani; M Barbacid
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

3.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro.

Authors:  S I Shin; V H Freedman; R Risser; R Pollack
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

4.  Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; K C Robbins; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Culture conditions affect photoreactivating enzyme levels in human fibroblasts.

Authors:  B M Sutherland; R Oliver
Journal:  Biochim Biophys Acta       Date:  1976-09-06

6.  Stage-specific transforming genes of human and mouse B- and T-lymphocyte neoplasms.

Authors:  M A Lane; A Sainten; G M Cooper
Journal:  Cell       Date:  1982-04       Impact factor: 41.582

7.  Cellular transforming genes.

Authors:  G M Cooper
Journal:  Science       Date:  1982-08-27       Impact factor: 47.728

8.  Carcinogenesis in tissue culture. 29: Neoplastic transformation of a normal human diploid cell strain, WI-38, with Co-60 gamma rays.

Authors:  M Namba; K Nishitani; T Kimoto
Journal:  Jpn J Exp Med       Date:  1978-08

9.  Anchorage-independent growth of normal human fibroblasts.

Authors:  D M Peehl; E J Stanbridge
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

10.  Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype.

Authors:  A Eva; S R Tronick; R A Gol; J H Pierce; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

View more
  6 in total

1.  Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.

Authors:  P J Hurlin; V M Maher; J J McCormick
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Structure and transforming potential of the human cot oncogene encoding a putative protein kinase.

Authors:  J Miyoshi; T Higashi; H Mukai; T Ohuchi; T Kakunaga
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

3.  Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.

Authors:  G E Milo; C Shuler; P Kurian; B T French; D G Mannix; I Noyes; J Hollering; N Sital; D Schuller; R W Trewyn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  Sulforaphane protects Microcystin-LR-induced toxicity through activation of the Nrf2-mediated defensive response.

Authors:  Nanqin Gan; Lixin Mi; Xiaoyun Sun; Guofei Dai; Fung-Lung Chung; Lirong Song
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-21       Impact factor: 4.219

5.  Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma.

Authors:  Xin-Yan Lu; Yaojuan Lu; Yi-Jue Zhao; Kim Jaeweon; Jason Kang; Li Xiao-Nan; Gouqing Ge; Rene Meyer; Laszlo Perlaky; John Hicks; Murali Chintagumpala; Wei-Wen Cai; Marc Ladanyi; Richard Gorlick; Ching C Lau; Debananda Pati; Michael Sheldon; Pulivarthi H Rao
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

6.  Human recipient cell for oncogene transfection studies.

Authors:  M A Tainsky; F L Shamanski; D Blair; G Vande Woude
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.